Literature DB >> 36068076

Efficacy of 3 Buprenorphine Formulations for the Attenuation of Hypersensitivity after Plantar Incision in Immunodeficient NSG Mice.

Justin D Arthur1, Eden D Alamaw1, Katechan Jampachairsri2, Patrick Sharp3, Claude Nagamine1, Monika K Huss1, Cholawat Pacharinsak1.   

Abstract

Buprenorphine is perhaps the most prescribed analgesic for management of postoperative pain in mice. Although various buprenorphine formulations are effective in commonly used immunocompetent mouse strains, a knowledge gap exists regarding its efficacy in immunodeficient mice. Here we used a plantar incision to evaluate the efficacy of 3 buprenorphine formulations for attenuating postoperative mechanical and thermal hypersensitivity in the immunodeficient NSG mouse strain. We also characterized the pharmacokinetics of these formulations over a 72-h period. We hypothesized that all 3 buprenorphine formulations evaluated-the standard preparation and 2 extended-release products (Bup-HCl, Bup-ER, and Bup-XR, respectively)-would attenuate postoperative mechanical and thermal hypersensitivity resulting from a plantar incision in NSG mice. Male and female NSG mice (n = 48) were allocated to 4 treatment groups: saline (0.9% NaCl, 5 mL/kg SC once); Bup-HCl (0.1 mg/kg SC, BID for 2 d); Bup-ER (1.0 mg/kg SC once); and Bup-XR (3.25 mg/kg SC once). Mechani- cal and thermal hypersensitivity assessments were conducted 24 h before surgery and at 4, 8, 24, 48, and 72 h afterward. All groups of mice showed mechanical and thermal hypersensitivity within the first 24 h after surgery. Behavioral pain indicators (guarding, toe-touching [intermittent partial weight bearing], licking the incision, vocalizations) were observed in some mice from each group at every postoperative time point. Plasma buprenorphine was measured in a separate group of mice and concentrations surpassed the suggested therapeutic level (1.0 ng/mL) for less than 4 h for Bup-HCl, for at least 24 h for Bup-ER, and for 72 h for Bup-XR. Our results indicate that at the dosages studied, these buprenorphine formulations do not adequately attenuate postoperative mechanical and thermal hypersensitivity in the plantar incisional model in NSG mice. These findings support the need for strain-specific analgesic protocols for mice used in research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36068076      PMCID: PMC9536821          DOI: 10.30802/AALAS-JAALAS-22-000058

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.706


  58 in total

Review 1.  Attacking pain at its source: new perspectives on opioids.

Authors:  Christoph Stein; Michael Schäfer; Halina Machelska
Journal:  Nat Med       Date:  2003-08       Impact factor: 53.440

2.  Endogenous opioid-mediated analgesia is dependent on adaptive T cell response in mice.

Authors:  Jérôme Boué; Catherine Blanpied; Pierre Brousset; Nathalie Vergnolle; Gilles Dietrich
Journal:  J Immunol       Date:  2011-03-21       Impact factor: 5.422

Review 3.  Laboratory routines cause animal stress.

Authors:  Jonathan P Balcombe; Neal D Barnard; Chad Sandusky
Journal:  Contemp Top Lab Anim Sci       Date:  2004-11

4.  Evaluation of an improved sustained-release buprenorphine formulation for use in mice.

Authors:  Jason R Healy; Jennifer L Tonkin; Stacey R Kamarec; Mitchell A Saludes; Sherif Y Ibrahim; Rae R Matsumoto; Jeffrey H Wimsatt
Journal:  Am J Vet Res       Date:  2014-07       Impact factor: 1.156

5.  Pharmacokinetics of sustained-release analgesics in mice.

Authors:  Lon V Kendall; Ryan J Hansen; Kathryn Dorsey; Sooah Kang; Paul J Lunghofer; Daniel L Gustafson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

Review 6.  The Common Cytokine Receptor γ Chain Family of Cytokines.

Authors:  Jian-Xin Lin; Warren J Leonard
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-09-04       Impact factor: 10.005

7.  Humanized mouse models to study human diseases.

Authors:  Michael A Brehm; Leonard D Shultz; Dale L Greiner
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-04       Impact factor: 3.243

8.  The animal pharmacology of buprenorphine, an oripavine analgesic agent.

Authors:  A Cowan; J C Doxey; E J Harry
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

9.  Effects of preemptive analgesia on pain and cytokine production in the postoperative period.

Authors:  Benzion Beilin; Hanna Bessler; Eduard Mayburd; Genady Smirnov; Arie Dekel; Israel Yardeni; Yehuda Shavit
Journal:  Anesthesiology       Date:  2003-01       Impact factor: 7.892

10.  Thermal latency studies in opiate-treated mice.

Authors:  Noam Schildhaus; Eliana Trink; Chirs Polson; Louis Detolla; Betty M Tyler; George I Jallo; Sino Tok; Michael Guarnieri
Journal:  J Pharm Bioallied Sci       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.